| Filed On | Filing |
|---|---|
| 08 Jul 2026 |
Form 4: Demsey Seth, Director
Received 5,515,658 shares by conversion |
| 08 Jul 2026 |
Form 4: Crystal John Adler Iii, Director
Received 4,053,677 shares by conversion |
| 08 Jul 2026 |
Form 4: Fairbairn Emily, Director
Received 1,205,282 shares by conversion |
| 02 Jul 2026 |
Form 4: Fairbairn Emily, Director
Received 135,800 shares as a grant or award · Disposed of 858.5403 Series C Preferred Stock (Disposition to Issuer) · Granted 858.5403 Series D Preferred Stock |
| 02 Jul 2026 |
Form 4: Moreland Christopher, CFO
Received 523,211 shares as a grant or award |
| 02 Jul 2026 |
Form 4: Fleury Patrick, Director
Received 100,000 shares as a grant or award · Granted 200,000 Stock Options (Right to Buy) |
| 02 Jul 2026 |
Form 4: Donofrio Nicholas M, Director
Received 50,000 shares as a grant or award |
| 02 Jul 2026 |
Form 4: Cullinan Brian, Director
Received 50,000 shares as a grant or award |
| 30 Jun 2026 |
Form 4: Cullinan Brian, Director
Received 48,209 shares by exercise or conversion ($44.4K) |
| 26 Jun 2026 |
Form 4: Caballero Ruben, Director
Received 29,197 shares by exercise or conversion ($26.9K) |
| 01 Apr 2026 |
Form 4: Demsey Seth, Director
Received 24,671 shares by conversion |
| 01 Apr 2026 |
Form 4: Crystal John Adler Iii, Chief Executive Officer
Received 18,132 shares by conversion |
| 01 Apr 2026 |
Form 4: Fairbairn Emily, Director
Received 9,231 shares by conversion |
| 19 Mar 2026 |
Form 4: Fairbairn Emily, Director
Granted 200,000 Stock option (right to buy) · Granted 9.2319 Series B Preferred Stock · Granted 2,063.8228 Series C Preferred Stock |
| 19 Mar 2026 |
Form 4: Cogan Jeremy, CFO
Received 37,000 shares as a grant or award |
| 17 Mar 2026 |
Form 4: Wirk Shaheen, Director
Received 10,000 shares by exercise or conversion ($12.5K) |
| 17 Mar 2026 |
Form 4: Fairbairn Emily, Director
Received 55,250 shares by exercise or conversion ($69.1K) |
| 28 Jan 2026 |
Form 4: Mastrototaro John, Director
Received 72,834 shares by exercise or conversion ($91K) · Sold 33,069 shares ($688K) |
| 28 Jan 2026 |
Form 4: Cogan Jeremy, CFO
Received 64,834 shares by exercise or conversion ($81K) · Sold 28,736 shares ($597K) |
| 22 Jan 2026 |
Form 4: Leabman Michael Aaron, Director
Received 11,174 shares as a grant or award |
Loading...